UA72755C2 - A method for the preparation of 3-amino-3-arylpropanoates and intermediary compounds for realizing the same - Google Patents
A method for the preparation of 3-amino-3-arylpropanoates and intermediary compounds for realizing the same Download PDFInfo
- Publication number
- UA72755C2 UA72755C2 UA2001096537A UA2001096537A UA72755C2 UA 72755 C2 UA72755 C2 UA 72755C2 UA 2001096537 A UA2001096537 A UA 2001096537A UA 2001096537 A UA2001096537 A UA 2001096537A UA 72755 C2 UA72755 C2 UA 72755C2
- Authority
- UA
- Ukraine
- Prior art keywords
- general formula
- compound
- differs
- alkyl
- aryl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 77
- 238000000034 method Methods 0.000 title claims abstract description 39
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 29
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 24
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 23
- 239000001257 hydrogen Substances 0.000 claims abstract description 23
- 125000001072 heteroaryl group Chemical group 0.000 claims abstract description 22
- 150000003839 salts Chemical group 0.000 claims abstract description 15
- 125000003118 aryl group Chemical group 0.000 claims abstract description 12
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 9
- 125000003107 substituted aryl group Chemical group 0.000 claims abstract description 8
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 14
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 14
- -1 3,5-dichlorophenyl Chemical group 0.000 claims description 10
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 239000003054 catalyst Substances 0.000 claims description 7
- 125000001424 substituent group Chemical group 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 238000010533 azeotropic distillation Methods 0.000 claims description 6
- 229910052763 palladium Inorganic materials 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 4
- 235000019253 formic acid Nutrition 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 239000012442 inert solvent Substances 0.000 claims description 4
- 125000001624 naphthyl group Chemical group 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 4
- 239000011541 reaction mixture Substances 0.000 claims description 4
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 3
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 claims description 3
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims description 2
- 150000001735 carboxylic acids Chemical class 0.000 claims 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims 1
- 101150078171 OSH3 gene Proteins 0.000 claims 1
- 241000256856 Vespidae Species 0.000 claims 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims 1
- 238000012876 topography Methods 0.000 claims 1
- 239000008096 xylene Substances 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 41
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 14
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 5
- 238000011031 large-scale manufacturing process Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical compound CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 150000002431 hydrogen Chemical group 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000007127 saponification reaction Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 125000001786 isothiazolyl group Chemical group 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 229910000077 silane Inorganic materials 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003178 Arterial thrombosis Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 238000006845 Michael addition reaction Methods 0.000 description 1
- 108010073038 Penicillin Amidase Proteins 0.000 description 1
- 206010038563 Reocclusion Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000004188 dichlorophenyl group Chemical group 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000002319 fibrinogen receptor antagonist Substances 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000003838 furazanyl group Chemical group 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- AFRJJFRNGGLMDW-UHFFFAOYSA-N lithium amide Chemical compound [Li+].[NH2-] AFRJJFRNGGLMDW-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- JUQKVXRLRKKRPL-UHFFFAOYSA-N methyl 3-oxo-3-pyridin-3-ylpropanoate Chemical compound COC(=O)CC(=O)C1=CC=CN=C1 JUQKVXRLRKKRPL-UHFFFAOYSA-N 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 238000007248 oxidative elimination reaction Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- QJZUKDFHGGYHMC-UHFFFAOYSA-N pyridine-3-carbaldehyde Chemical compound O=CC1=CC=CN=C1 QJZUKDFHGGYHMC-UHFFFAOYSA-N 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 229910052717 sulfur Chemical group 0.000 description 1
- 239000011593 sulfur Chemical group 0.000 description 1
- BNWCETAHAJSBFG-UHFFFAOYSA-N tert-butyl 2-bromoacetate Chemical compound CC(C)(C)OC(=O)CBr BNWCETAHAJSBFG-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/30—Preparation of optical isomers
- C07C227/32—Preparation of optical isomers by stereospecific synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12566999P | 1999-03-22 | 1999-03-22 | |
| PCT/US2000/007493 WO2000056716A1 (en) | 1999-03-22 | 2000-03-21 | Synthesis of 3-amino-3-aryl propanoates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA72755C2 true UA72755C2 (en) | 2005-04-15 |
Family
ID=22420854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2001096537A UA72755C2 (en) | 1999-03-22 | 2000-03-21 | A method for the preparation of 3-amino-3-arylpropanoates and intermediary compounds for realizing the same |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US6258956B1 (enExample) |
| EP (1) | EP1163223A1 (enExample) |
| JP (1) | JP2002540101A (enExample) |
| KR (1) | KR20020015031A (enExample) |
| CN (1) | CN1364159A (enExample) |
| AU (1) | AU776300B2 (enExample) |
| BR (1) | BR0009856A (enExample) |
| CA (1) | CA2367971A1 (enExample) |
| HR (1) | HRP20010768A2 (enExample) |
| HU (1) | HUP0201263A3 (enExample) |
| MX (1) | MXPA01009617A (enExample) |
| NZ (1) | NZ514379A (enExample) |
| RU (1) | RU2225859C2 (enExample) |
| SK (1) | SK13592001A3 (enExample) |
| UA (1) | UA72755C2 (enExample) |
| WO (1) | WO2000056716A1 (enExample) |
| YU (1) | YU74501A (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU776300B2 (en) | 1999-03-22 | 2004-09-02 | Ortho-Mcneil Pharmaceutical, Inc. | Synthesis of 3-amino-3-aryl propanoates |
| US7907988B2 (en) * | 2002-04-01 | 2011-03-15 | Ilan Elias | Method and device for generating a passive movement in a diagnostic device |
| JP4705031B2 (ja) * | 2003-09-18 | 2011-06-22 | 高砂香料工業株式会社 | アミノ酸誘導体を製造するためのケト酸誘導体の還元的不斉アミノ化 |
| JP5137819B2 (ja) * | 2005-05-19 | 2013-02-06 | ザ・ホンコン・ポリテクニック・ユニバーシティ | α−イミノエステルの不斉アルキニル化のための方法 |
| CN107879963A (zh) * | 2016-09-29 | 2018-04-06 | 中国科学院上海药物研究所 | 新型手性配体、金属螯合物、多种非天然氨基酸、马拉维诺及其关键中间体的合成方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE58243B1 (en) | 1983-12-07 | 1993-08-11 | Lonza Ag | A process for the preparation of optically-active 3-amino carboxylic acids |
| US5254573A (en) * | 1991-10-15 | 1993-10-19 | Monsanto Company | Substituted heterocyclic derivatives useful as platelet aggregation inhibitors |
| NZ332585A (en) * | 1996-05-01 | 2000-04-28 | Ortho Mcneil Pharm Inc | Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
| ATE209179T1 (de) | 1996-07-12 | 2001-12-15 | Searle & Co | Asymmetrische synthese von chiralen beta- aminosäuren |
| HRP20010766A2 (en) | 1999-03-22 | 2002-12-31 | Ortho Mcneil Pharm Inc | Process of preparing 3s-3-amino-3-aryl propionic acid and derivatives thereof |
| ES2199805T3 (es) | 1999-03-22 | 2004-03-01 | Ortho-Mcneil Pharmaceutical, Inc. | Procedimiento para la preparacion de acido (s-(r*s*))-beta-(((1-(1-oxo-3-4-piperidinil)propil)-3-piperidinil)carbonil)amino)-3-piridinoproanoico y derivados. |
| AU776300B2 (en) | 1999-03-22 | 2004-09-02 | Ortho-Mcneil Pharmaceutical, Inc. | Synthesis of 3-amino-3-aryl propanoates |
-
2000
- 2000-03-21 AU AU39064/00A patent/AU776300B2/en not_active Ceased
- 2000-03-21 WO PCT/US2000/007493 patent/WO2000056716A1/en not_active Ceased
- 2000-03-21 RU RU2001128428/04A patent/RU2225859C2/ru active
- 2000-03-21 NZ NZ514379A patent/NZ514379A/en unknown
- 2000-03-21 BR BR0009856-6A patent/BR0009856A/pt not_active Application Discontinuation
- 2000-03-21 JP JP2000606578A patent/JP2002540101A/ja active Pending
- 2000-03-21 MX MXPA01009617A patent/MXPA01009617A/es unknown
- 2000-03-21 EP EP00918213A patent/EP1163223A1/en not_active Withdrawn
- 2000-03-21 KR KR1020017012070A patent/KR20020015031A/ko not_active Withdrawn
- 2000-03-21 YU YU74501A patent/YU74501A/sh unknown
- 2000-03-21 CA CA002367971A patent/CA2367971A1/en not_active Abandoned
- 2000-03-21 HR HR20010768A patent/HRP20010768A2/hr not_active Application Discontinuation
- 2000-03-21 HU HU0201263A patent/HUP0201263A3/hu unknown
- 2000-03-21 SK SK1359-2001A patent/SK13592001A3/sk unknown
- 2000-03-21 UA UA2001096537A patent/UA72755C2/uk unknown
- 2000-03-21 US US09/532,799 patent/US6258956B1/en not_active Expired - Lifetime
- 2000-03-21 CN CN00807449A patent/CN1364159A/zh active Pending
-
2001
- 2001-05-15 US US09/858,078 patent/US20010029300A1/en not_active Abandoned
-
2002
- 2002-07-15 US US10/197,286 patent/US6610855B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| HU0201263D0 (enExample) | 2002-05-29 |
| KR20020015031A (ko) | 2002-02-27 |
| JP2002540101A (ja) | 2002-11-26 |
| MXPA01009617A (es) | 2003-07-21 |
| SK13592001A3 (sk) | 2002-11-06 |
| US20010029300A1 (en) | 2001-10-11 |
| NZ514379A (en) | 2003-10-31 |
| CA2367971A1 (en) | 2000-09-28 |
| EP1163223A1 (en) | 2001-12-19 |
| HRP20010768A2 (en) | 2002-12-31 |
| RU2225859C2 (ru) | 2004-03-20 |
| AU776300B2 (en) | 2004-09-02 |
| AU3906400A (en) | 2000-10-09 |
| US20020198400A1 (en) | 2002-12-26 |
| BR0009856A (pt) | 2002-02-05 |
| US6610855B2 (en) | 2003-08-26 |
| HUP0201263A2 (en) | 2002-09-28 |
| HUP0201263A3 (en) | 2003-05-28 |
| CN1364159A (zh) | 2002-08-14 |
| WO2000056716A1 (en) | 2000-09-28 |
| YU74501A (sh) | 2004-07-15 |
| US6258956B1 (en) | 2001-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4770174B2 (ja) | グルタミン酸誘導体及びピログルタミン酸誘導体の製造方法並びに新規製造中間体 | |
| JPH0529216B2 (enExample) | ||
| CN101657462A (zh) | 卡培他滨的制备方法及其中间体 | |
| JP2002265444A (ja) | １−（３−ベンジルオキシプロピル）−５−（２−置換プロピル）インドリン誘導体およびその使用方法 | |
| EP0309324A1 (fr) | Procédé de synthèse d'alpha amino N alkyles et de leurs esters. Application à la synthèse de carboxyalkyl dipeptides | |
| UA72755C2 (en) | A method for the preparation of 3-amino-3-arylpropanoates and intermediary compounds for realizing the same | |
| JPS6013775A (ja) | 光学活性３−（ｐ−アルコキシフエニル）グリシツド酸アルカリ金属塩の製造法 | |
| CN119504830A (zh) | 一种莫奈太尔关键中间体及其拆分方法 | |
| JP2007517797A (ja) | 高化学的ｒ−５−（２−（２−エトキシフェノキシエチルアミノ）プロピル）−２−メトキシベンゼンスルホンアミド塩酸塩の調製 | |
| EP0427587A1 (fr) | Procédé de préparation de l'AZT (azido-3'-désoxy-3'-thymidine) et de composés apparentés | |
| JPS5936914B2 (ja) | セフアロスポリン類縁体 | |
| KR100275978B1 (ko) | (-)-n-메틸-n-(4-(4-페닐-4-아세틸아미노피페리딘-1-일)-2-(3,4-디클로로페닐)부틸)벤즈아미드 및 약학적으로 허용가능한 그의 염의 제조방법 | |
| KR20020016617A (ko) | 3ｓ-3-아미노-3-아릴 프로피온산 및 그의 유도체의 제조방법 | |
| KR100888905B1 (ko) | 4-(이미다졸-1-일)벤젠술폰아미드 유도체의 제조 방법 | |
| KR100850558B1 (ko) | 아토르바스타틴의 효율적인 제조방법 | |
| JP4491104B2 (ja) | カルボニル化合物の製造方法 | |
| KR100343551B1 (ko) | 4-알콕시카르보닐-5-클로로피라졸 유도체의 제조방법 | |
| CN115368283A (zh) | 一种手性结构或非手性结构的顺式-3-氟-4-羟基吡咯烷及其衍生物的制备方法 | |
| JPH07267950A (ja) | ５−クロロ−ｎ−（４，５−ジヒドロ−１ｈ−イミダゾール−２−イル）−２，１，３−ベンゾチアジアゾール−４−アミン又はその酸付加塩の製造方法 | |
| PL185120B1 (pl) | Sposób┴wytwarzania┴1-{[3-(5-nitro-2-furylo)-2-propenylideno]-amino}-2,4-imidazolidynodionu | |
| CN120112512A (zh) | 制备(z)-3-(2-(5-溴-1h-吲哚-3-基)-2-氰基乙烯基)-4-甲氧基苯甲腈的方法 | |
| JP2003192651A (ja) | ３−アミノカルボン酸およびそのエステルの製法 | |
| JPH05163273A (ja) | １３ｃで標識されたアデニン誘導体の製造法 | |
| JPS6327348B2 (enExample) | ||
| WO2006088132A1 (ja) | ピリジン酸化型化合物、並びに、これを用いたカルボン酸誘導体及びその光学活性体の製造方法 |